caspofungin

(redirected from Cancidas)

caspofungin

 [kas″po-fun´jin]
an antifungal used as the acetate salt in the treatment of invasive aspergillosis, administered intravenously.

caspofungin

(kas'pō-fŭn-jin),
A member of the echinocandin class of antifungal compounds targeting the fungal cell wall.
References in periodicals archive ?
Pharmaceutical sales growth for the quarter was also partially offset by the impacts from the loss of market exclusivity for ZETIA (ezetimibe) and VYTORIN (ezetimibe/simvastatin), medicines for lowering LDL cholesterol; INVANZ (ertapenem sodium), an antibiotic; CANCIDAS (caspofungin acetate for injection), an antifungal; as well as biosimilar competition for REMICADE (infliximab), a treatment for inflammatory diseases, in the company's marketing territories in Europe.
Mylan had numerous drug launches during the year, including Imatinib Mesylate Tablets, 100 mg and 400 mg, a generic version of Novartis's Gleevec Tablets, and Caspofungin Acetate for Injection, one of the first generic versions of Merck's Cancidas. Also launched was Bivalirudin for Injection, 250 mg single-dose vial, a generic version of Angiomax from The Medicines Company.
The four drugs are Cubicin, indicated for complex skin infections and bloodstream infections, with sales of $1.17 billion; Vytorin, a cholesterol drug that contributes $1.12 billion; Invanz, used to treat a variety of bacterial infections and generating $544 million in sales; and Cancidas, prescribed for treatment of candidemia and other Candida infections, with annual sales of $540 million.
Caspofungin exclusive supply medicines, CANCIDAS articles 50 and 71 mg and posaconazole 100 mg Noxafil article.
Other useful agents may be voriconazole (VFend), caspofungin (Cancidas), micafungin (Mycamine), or posaconazole (Noxafil).
In situations where the disease becomes refractory, a broader spectrum drug of a more potent nature such as voriconazole (Vfend; Pfizer Labs, New York, NY, USA), caspofungin (Cancidas; Merck & CO., Whitehouse Station, NJ, USA), and amphotericin B (Fungizone; Bristol-Myers Squibb Co., Princeton, NJ, USA) is suggested.
Ltd., India), Caspofungin (CSP) (Cancidas [TM], Merck & Co.
(Whitehouse Station NJ) said it is suing to stop Novartis AG's Sandoz division from selling a generic version of its antifungal drug Cancidas. Filing the patent infringement lawsuit will keep the U.S.
Decision Resources (Waltham, MA), one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, said that, because of their improvements in safety and efficacy, physicians are increasingly prescribing next-generation antifungals such as Pfizer's Vfend, Schering-Plough's Noxafil, Merck's Cancidas, Astellas' Mycamine and Pfizer's Eraxis.
He noted that he has worked with caspofungin (Cancidas) quite a bit and has found that it greatly extends Candida coverage.
He noted that he has worked with caspo-fungin (Cancidas) quite a bit and has found that it greatly extends Candida coverage.
There are no human reports of pregnancy exposures to caspofungin (Cancidas), rated C, which is embryotoxic in rats and rabbits at systemic exposures equal to those used in humans.